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Abstract
The application of metabolic engineering in Escherichia coli has resulted in the generation of strains
with the capacity to produce metabolites of commercial interest. Biotechnological processes with
these engineered strains frequently employ culture media containing glucose as the carbon and
energy source. In E. coli, the phosphoenolpyruvate:sugar phosphotransferase system (PTS)
transports glucose when this sugar is present at concentrations like those used in production
fermentations. This protein system is involved in phosphoenolpyruvate-dependent sugar transport,
therefore, its activity has an important impact on carbon flux distribution in the
phosphoenolpyruvate and pyruvate nodes. Furthermore, PTS has a very important role in carbon
catabolite repression. The properties of PTS impose metabolic and regulatory constraints that can
hinder strain productivity. For this reason, PTS has been a target for modification with the purpose
of strain improvement. In this review, PTS characteristics most relevant to strain performance and
the different strategies of PTS modification for strain improvement are discussed. Functional
replacement of PTS by alternative phosphoenolpyruvate-independent uptake and phosphorylation
activities has resulted in significant improvements in product yield from glucose and productivity
for several classes of metabolites. In addition, inactivation of PTS components has been applied
successfully as a strategy to abolish carbon catabolite repression, resulting in E. coli strains that use
more efficiently sugar mixtures, such as those obtained from lignocellulosic hydrolysates.
Review
Metabolic engineering can be defined as the purposeful
modification of cellular activities with the aim of strain
improvement [1]. Development of microbial strains for
the production of metabolites is based primarily on the
application of recombinant DNA technology to alter the
properties of the metabolic network by modifying the
level of activity or the properties of specific enzymes.
These principles have been applied to the generation of a
large number of Escherichia coli strains, designed for the
production of commercially important compounds [2].
Cultures with these engineered strains usually employ
media containing glucose. This sugar is nowadays the
most utilized raw material in industrial fermentations
with E. coli, mostly because it is relatively inexpensive and
it is the preferred carbon and energy source for this bacte-
rium. As a component of culture media, glucose provides
carbon atoms for biomass and product generation. The
cell's capacity to uptake and metabolize this carbohydrate
has a profound impact on its growth rate and productiv-
ity. Thus, it can be expected that modifications to glucose
transport systems should have and important impact on
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the cell's physiology and this, in turn, can either improve
or become detrimental in an industrial production con-
text. The purpose of this review is to summarize the char-
acteristics of glucose uptake systems in E. coli and discuss
examples where their modification in wild type or engi-
neered production strains has resulted in improved
performance.
Glucose transport systems in Escherichia coli
A distinctive feature of E. coli and other gram-negative bac-
teria is the presence of two concentric membranes sur-
rounding its cytoplasm. The space between these two
membranes is the periplasm (Fig. 1). The outer and cyto-
plasmic membranes constitute a hydrophobic barrier to
polar compounds. To control the inward and outward
flow of molecules across these barriers, the bacterial cell
synthesizes proteins that form channels. The outer mem-
brane constitutes the first barrier to the entry of carbohy-
drates,  E. coli contains about 105 channels formed by
specialized proteins called porins [3]. The proteins OmpC
and OmpF are the most abundant porins present under
typical laboratory growth conditions, representing up to
2% of the total cellular protein [4]. Their relative abun-
dance is influenced by various factors such as medium
osmolarity, temperature and growth phase [5-7]. It has
been shown that these two porins constitute the main
entry channels for glucose into the periplasm when this
sugar is present at a concentration higher than 0.2 mM
[8,9]. In experiments with reconstituted liposomes, the
diffusion rate for glucose was found to be about twofold
higher through OmpF than through the OmpC channel
[10]. Under conditions of glucose limitation, synthesis of
the outer membrane glycoporin LamB is induced [9]. This
protein permeates several carbohydrates including mal-
tose, maltodextrins and glucose [11]. It has been demon-
strated that under external submicromolar concentrations
of glucose, LamB contributes about 70% of the total glu-
cose import capacity of the cell [9].
Glucose diffusion by porins through the outer membrane
is a passive process. The driving force for glucose internal-
ization into the periplasm is its active transport into the
The phosphoenolpyruvate:sugar phosphotransferase system and other glucose transport systems in Escherichia coli Figure 1
The phosphoenolpyruvate:sugar phosphotransferase system and other glucose transport systems in Escherichia coli.
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cytoplasm. Due to the presence of active transport systems
in the cytoplasmic membrane, it can be assumed that glu-
cose concentration in the periplasm is very low. Once
inside the periplasm, glucose can be internalized into the
cytoplasm by the phosphoenolpyruvate:sugar phospho-
transferase system (PTS). This protein system belongs to
the group translocator family of transporters, which are
widespread in bacteria and absent in Archaea and eukary-
otic organisms [12,13]. PTS participates in the transport
and phosphorylation of several sugars. The system is com-
posed of the soluble and non sugar-specific protein com-
ponents Enzyme I (EI) and the phosphohistidine carrier
protein (HPr), encoded by genes ptsHI (Fig. 1). These pro-
teins relay a phosphoryl group from PEP to the sugar-spe-
cific enzymes IIA and IIB. The last component of this
system, IIC (in some cases also IID), is an integral mem-
brane protein permease that recognizes and transports the
sugar molecules, which are phosphorylated by compo-
nent IIB. There are 21 different identified enzyme II com-
plexes encoded in the E. coli chromosome, that are
involved in the transport of about 20 different carbohy-
drates [14]. In E. coli, the enzyme II complexes IIGlc and
IIMan are involved in glucose import. The glucose-specific
IIGlc complex is composed of the soluble IIAGlc enzyme
and the integral membrane permease IICBGlc, encoded by
genes crr and ptsG, respectively. Reported Km and Vmax val-
ues for IIGlc with glucose as substrate are in the range of 3–
10 µM and 126 µmol min-1 g-1, respectively [15,16]. The
mannose IIMan  complex is composed of the IIABMan
homodimer enzyme and the integral membrane per-
mease IICDMan. These proteins are encoded in the
manXYZ operon. In addition to mannose, these proteins
can also transport with similar efficiently glucose, fruc-
tose, N-acetylglucosamine and glucosamine [17].
Reported Km and Vmax values for IIMan with glucose as sub-
strate are 15 µM and 72 µmol min-1 g-1, respectively [16].
In a wild type strain growing with glucose as the carbon
source,  ptsG  is induced and the manXYZ  operon is
repressed. Inactivation of the genes encoding the IIGlc
complex abolishes repression of manXYZ and the result-
ing mutant now transports glucose with the IIMan com-
plex, displaying a growth rate corresponding to
approximately 84% of that observed in a wild type strain
[18].
Glucose can also be actively transported into the cyto-
plasm by systems that are normally involved in galactose
internalization. The genes coding for these transporters
and for enzymes involved in galactose metabolism are
normally induced by the presence of galactose in the
growth medium. However, it has been demonstrated that
under growth conditions where external glucose concen-
tration is lower than 1 µM, the genes encoding these sys-
tems are maximally induced in the absence of galactose
[19,20]. A similar response has been observed in an E. coli
strain lacking the PTS and growing in a medium with a rel-
atively high glucose concentration (2 g/l) [21]. Analysis of
strains growing in glucose-limited conditions revealed
that induction of these genes is caused by the intracellular
synthesis of galactose that functions as an autoinducer of
the system [19]. One of the genes induced under condi-
tions of glucose limitation is galP, that encodes the low
affinity galactose:H+  symporter GalP. It constitutes an
integral membrane protein belonging to the major facili-
tator superfamily (MFS) of the electrochemical potential-
driven class of transporters. The GalP protein can import
glucose with a Km of 10.2 µM and a Vmax of 15.6 µmol min-
1 g-1 [22]. The genes in the mglABC operon encode an ATP-
binding protein, a galactose/glucose periplasmic binding
protein and an integral membrane transporter protein,
respectively. These proteins constitute the Mgl system,
that is also involved in galactose/glucose (methyl galacto-
side) import. This high affinity porter belongs to the ATP-
binding cassette (ABC) superfamily of the primary active
class of transporters. The Mgl proteins together with LamB
constitute a high-affinity glucose transport system that is
induced when this sugar is present at a very low concen-
tration [19]. Glucose internalized by GalP or the Mgl sys-
tems must be phosphorylated to enter the Embden-
Meyerhof-Parnas (EMP) glycolytic pathway. The enzyme
glucokinase, encoded by glk, catalyzes the ATP-dependent
phosphorylation of glucose in the cytoplasm [23]. Glu-
cokinase activity in E. coli is not essential when glucose is
abundant and it is transported by PTS. However, in condi-
tions of glucose limitation or in a mutant lacking PTS,
inactivation of glk severely impairs growth capacity [17].
As it can be observed in figure 1 and Table 1, the energetic
costs of importing glucose differ significantly among these
systems. Since glucose must be phosphorylated in order to
enter the EMP glycolytic pathway, a fair comparison must
include transport and phosphorylation reactions. It can
be observed that PTS is the most efficient system as it con-
sumes one mol of PEP for each mol of internalized and
phosphorylated glucose. The energetic equivalent of one
mol of PEP is one mol of ATP, since the conversion of PEP
into pyruvate (PYR) by pyruvate kinase would yield a mol
of ATP by substrate-level phosphorylation. The high-affin-
ity Mgl-glucokinase system is the most expensive energet-
ically, as it consumes two mol of ATP for every mol of
glucose that is internalized and phosphorylated. Finally,
GalP and glucokinase transports and phosphorylates glu-
cose at the expense of one mol of H+ that is internalized
into the cytoplasm and one mol of ATP.
Laboratory and industrial scale cultures with E. coli
employ media containing glucose in a wide range of
concentrations. Furthermore, feeding strategies are usu-
ally implemented to precisely control glucose concentra-
tion through different stages in a production process.Microbial Cell Factories 2005, 4:14 http://www.microbialcellfactories.com/content/4/1/14
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However, even under these different scenarios, glucose
will almost always be present at a concentration that can
be transported efficiently by PTS. Thus, it can be assumed
that in industrial production fermentations and most lab-
oratory-scale cultures, glucose uptake and phosphoryla-
tion will be dependent almost entirely on the IIGlc PTS
complex. Notwithstanding its efficiency as a transport sys-
tem, PTS imposes several physiological constraints that
can hinder some production processes. In the next sec-
tions, the characteristics of PTS that can limit productivity
will be discussed and strategies to overcome them will be
presented.
Increasing PEP metabolic availability for the 
production of shikimate pathway intermediates 
and amino acids
By coupling glucose internalization to PEP-dependent
phosphorylation, the PTS provides a tight linkage
between sugar transport and its subsequent metabolism.
Fig. 2 shows central metabolism reactions related to PTS
activity. It can be observed that PEP is a link between the
EMP glycolytic pathway and PTS, together forming a
phosphorylation circuit. In addition to its role as a phos-
phate donor for PTS, PEP participates in several metabolic
reactions. It is a precursor in several biosynthetic path-
ways and also participates directly in energy-generating
reactions such as substrate-level phosphorylation of ADP
or indirectly as a precursor of acetyl-CoA. The relative car-
bon flux originating from the PEP node into the different
metabolic pathways has been determined experimentally.
When E. coli grows in minimal medium containing glu-
cose as the carbon source, PTS consumes 50% of available
PEP, whereas the reactions catalyzed by PEP carboxylase,
pyruvate kinases, UDP-N-acetylglucosamine enolpyruvyl
transferase and 3-deoxy-D-arabino-heptulosonate 7-phos-
phate (DAHP) synthase consume approximately 16%,
15%, 16% and 3%, respectively [24-26].
The shikimate (SHIK) or common aromatic pathway is a
source of compounds with commercial applications that
include the aromatic amino acids tryptophan, tyrosine
and phenylalanine. Carbon flux into the common aro-
matic pathway starts with the condensation of D-eryth-
rose 4-phosphate (E4P) and PEP to yield DAHP, in a
reaction catalyzed by the enzyme DAHP synthase (Fig. 2).
It has been determined that carbon flux partitioning at the
PEP node is the major determinant of yield for aromatic
Table 1: Kinetic parameters for glucose transporters and energetic costs for glucose internalization and phosphorylation*.
Transporter Km Vmax Energetic costsa
IIGlc complex 3–10 µM1 2 6   µmol min-1 g-1 1 PEP
IIMan complex 15 µM7 2   µmol min-1 g-1 1 PEP
GalP 10.2 µM 15.6 µmol min-1 g-1 1 H+ + 1 ATP
MglABC N.D N.D. 2 ATP
Glf 4.1 mM 75 µmol min-1 g-1 1 ATP
* N.D., not determined.
a The energetic cost equivalent of 1 mol of PEP is 1 mol of ATP.
Central pathways related to PTS glucose transport and  metabolism Figure 2
Central pathways related to PTS glucose transport and 
metabolism.
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compounds synthesized from glucose in E. coli [27-30].
Stoichiometric analyses of the metabolic network
involved in aromatics synthesis indicates that the maxi-
mum theoretical molar yield from glucose could double
in a strain that transports glucose without coupling this
process to PEP utilization [31,32]. For this reason, several
research groups have explored strategies for developing E.
coli strains that can uptake glucose without coupling this
process to PEP-dependent phosphorylation. Inactivation
of the ptsHI-crr operon is the most common approach for
generating PTS- strains. Strains with this genetic modifica-
tion lack the general PTS proteins involved in the phos-
photransfer relay to any of the PTS complexes. Therefore,
the resulting PTS- strains will exhibit a very limited capac-
ity to transport and phosphorylate glucose (PTS-Glc- phe-
notype), supported mainly by the GalP, Mgl and
glucokinase systems [21]. The severely reduced capacity to
transport glucose would be a serious drawback, rendering
a PTS- Glc- strain unsuitable for production purposes as it
would display very low specific growth rate and produc-
tivity. For this reason, different strategies have been inves-
tigated for the generation, from PTS- strains, of derivatives
that can transport glucose efficiently by a PTS-independ-
ent mechanism.
E. coli strains lacking a functional PTS but capable of inter-
nalizing glucose at a rate similar to that of a PTS+ strain
(PTS- Glc+ phenotype), have been selected for their capac-
ity to grow rapidly using glucose as the sole carbon source
in a continuous culture [33]. Characterization of these
mutants has revealed that glucose is now transported and
phosphorylated by an alternative transport system: galac-
tose permease (GalP) and glucokinase (Glk), that uses
ATP as phosphate donor instead of PEP [33,26]. These
PTS- Glc+ strains have been modified by metabolic engi-
neering to direct carbon flow to the SHIK pathway and
they were compared to equally modified PTS+ strains with
regard to yield from glucose in the synthesis of DAHP and
phenylalanine. These studies showed that the yield from
glucose in the synthesis of DAHP and phenylalanine
increased by 65% and 57%, respectively, when compared
to isogenic PTS+ strains [32-34].
Generation of PTS- Glc+ strains has also been achieved by
expressing from a plasmid genes coding for non PTS-
dependent glucose transporters. The first example of this
approach was the expression of the genes glfZm and glkZm
encoding, respectively, a glucose facilitator (Glf) and glu-
cokinase from Zymomonas mobilis in an E. coli strain lack-
ing functional glucose and mannose PTS complexes and
glucokinase [35]. The resulting recombinant strain recov-
ered glucose uptake capacity, increasing its specific growth
rate from 0.01 to 0.53 h-1. The Z. mobilis Glf or glucose
uniporter belongs to the sugar porter family of the mayor
facilitator superfamily. This type of permease does not use
energy during transport. Biochemical characterization of
Glf revealed that it can transport glucose (Km of 4.1 mM
and Vmax of 75 µmol min-1g-1) and fructose (Km of 39 mM
and Vmax of 93 µmol min-1 g-1) (see Table 1) [36]. More
recently, the effects of different expression levels of native
galP and glk on glucose consumption and growth capacity
in a PTS-Glc- E. coli strain were studied [37]. Strain VH32
is an E. coli derivative of W3110 having a deletion of the
ptsHI-crr operon that displays a specific growth rate of
0.03 h-1 when using glucose as the only carbon source.
When this strain was transformed with a plasmid express-
ing glk, no increase in growth rate was observed. In con-
trast, expression of galP in VH32 increased specific growth
rate to 0.55 h-1 and simultaneous expression of both glk
and galP caused VH32 to grow at a specific rate identical
to that of the PTS+ parent strain. These results showed that
glucose internalization and not phosphorylation is the
main limiting factor for rapid growth on glucose for this
PTS- Glc- strain. These two approaches for generating PTS-
Glc+ strains have been compared with regard to their
impact on the yield from glucose in the synthesis of 3-
dehydroshikimic acid (DHS) and intermediates from the
SHIK pathway in engineered E. coli strains [38]. In fed-
batch cultures, a strain transporting glucose by PTS syn-
thesized DHS and SHIK pathway intermediates with 33%
(mol/mol) yield from glucose. Under the same culture
conditions, PTS- strains expressing glfZm and glkZm or hav-
ing glucose transport and phosphorylation dependent on
high-level expression of native galP and glk, synthesized
DHS and SHIK pathway intermediates with 41% and 43%
(mol/mol) yield from glucose, respectively.
It can be expected that replacement of PTS by an ATP-
dependent glucose transport and phosphorylation system
should increase the yield from glucose not only for metab-
olites derived from the SHIK pathway, but also for some
compounds having PEP as a precursor. One example is
the synthesis of the amino acid asparagine (ASN). This
metabolite is synthesized from aspartate (ASP), whose
precursor is PEP-derived oxaloacetate (OAA) (Fig. 2). A
recent study based on flux balance analysis of gene knock-
outs or additions in an E. coli metabolic model, predicted
that replacement of PTS activity by an ATP-dependent glu-
cose transport system should increase asparagine yield by
16.5% [39].
Reduction of overflow metabolism: acetate 
production reduction and increasing 
recombinant protein production
Acetate is one of the fermentation products generated by
E. coli when it grows using glucose in oxygen-limited con-
ditions. Pyruvate formate-lyase catalyzes the conversion
of PYR and coenzyme A (CoA) into acetyl-CoA (AcCoA)
and formate. The enzyme phosphotransacetylase (Pta)
catalyses an acyl transfer reaction to convert AcCoA and PiMicrobial Cell Factories 2005, 4:14 http://www.microbialcellfactories.com/content/4/1/14
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into acetyl phosphate (Ac~P) and CoA. Finally, acetate
kinase (Ack) catalyzes the substrate-level phosphorylation
of ADP to yield ATP and acetate. These series of reactions
provide the cell with a source of ATP under conditions
where aerobic respiration is not possible [40]. However, it
is known that E. coli can also synthesize a significant
amount of acetate under aerobic conditions [41,42]. It has
been determined that this condition is the result of the
combined high rates of glucose uptake by PTS and glucose
catabolism by the EMP pathway that result in a rate of
AcCOA synthesis surpassing the capacity of the tricarbox-
ylic acid (TCA) cycle to completely consume this metabo-
lite. Part of the excess AcCOA is diverted into the Ack-Pta
pathway to generate acetate [43]. The accumulation of
acetate in culture media is an important problem in
industrial fermentations since this organic acid inhibits
cell growth and recombinant protein production [44]. A
common approach to reduce acetate accumulation is the
application of glucose feeding strategies to limit glucose
availability and the genetic modification of central meta-
bolic pathways directly related to acetate biosynthesis
[45,46]. In addition, modification of glucose transport
capacity is another successful approach at reducing acetate
production rate under aerobic conditions. The metaboli-
cally inert glucose analog methyl α -glucoside (α -MG) has
been employed as a competitive inhibitor of PTS glucose
transport [18]. In this report, the addition of 6.67 g/l of α -
MG to E. coli cultures growing in complex medium sup-
plemented with 20 g/l of glucose resulted in a 54% reduc-
tion in acetate concentration, 39% increase in the specific
activity of a recombinant protein and 15% increase in the
final biomass concentration, when compared to cultures
lacking α -MG. In a different approach, inactivation of ptsG
was evaluated as a strategy to reduce glucose uptake capac-
ity. In this study, it was determined that cultures of a ptsG-
strain growing in complex medium supplemented with
15 or 20 g/l of glucose resulted in significant reduction of
acetate secretion and more than 50% increase in recom-
binant protein synthesis when compared to wild type
strain cultures [47]. Similar results have been reported
with a PTS- Glc+ strain having a deletion of the ptsHI-crr
operon and obtained by selection from a continuous cul-
ture [33]. Its characterization when growing in minimal
medium cultures with glucose as carbon source revealed
that it accumulates 80% less acetate than an isogenic PTS+
strain [48].
Transcriptional repression of genes encoding PTS compo-
nents has been reported as a successful method to
decrease glucose uptake rate and acetate buildup in wild
type E. coli strain cultures. The mlc gene encodes the regu-
latory protein Mlc that represses, among others, the ptsHI
and ptsG genes [49] (Fig. 3). Cultures of a recombinant
strain having the mlc gene expressed from a multicopy
plasmid and growing in complex medium with 0.4% glu-
cose, showed a 50% reduction in acetate accumulation
and increased capacity to consume this acid when com-
pared to a strain having only a chromosomal copy of mlc
[50].
Increasing production of glycolytic and TCA 
cycle intermediates
The PTS is one of several cellular activities that influences
the PEP/PYR ratio and carbon flux distribution originat-
ing from these two central metabolic nodes. As the main
PEP-consuming activity when E. coli grows on glucose or
other PTS sugars, it can be expected that modification or
elimination of PTS components should have a significant
impact on carbon flux distribution in central metabolism.
To ascertain some of the effects of PTS inactivation on car-
bon metabolism, metabolic flux analysis using 13C-
labeled glucose and NMR spectroscopy has been per-
formed [26]. This study revealed significant carbon flux
distribution differences among PTS+ and PTS- strains at the
EMP, pentose phosphate pathway (PPP) and TCA cycle.
As an example of the results obtained, the relative carbon
fluxes into the EMP pathway and the PPP corresponded to
76.6% and 22.3% for the PTS+ strain and 93.1% and 5.3%
for the PTS- Glc+strain, respectively. Most of the changes
observed in metabolic flux distribution in the PTS- Glc+
strain could not have been predicted based on our current
knowledge about the properties of the central metabolic
network in E. coli. Further experimental and theoretical
analysis, now in progress by several research groups, will
be required to fully understand the connections between
PTS and central metabolism.
The effect of PTS replacement by the combined activities
of GalP and glucokinase on glycolytic flux to fermentation
products has been reported [37]. The high-level expres-
sion of galP and glk in a PTS- Glc- strain restored glucose
transport and resulted in a two-fold increase in the specific
rate of acetate production when compared to a PTS+
strain. Both of these strains were transformed with a plas-
mid carrying the Zymomonas mobilis genes pdcZm and adh-
BZm  encoding pyruvate decarboxylase and alcohol
dehydrogenase II, respectively. These enzymes generate a
pathway for the synthesis of ethanol from PYR [51]. When
these two strains were grown in complex medium
supplemented with glucose, a two-fold increase in the
specific rate of ethanol production was observed when
comparing the PTS- galP+ glk+ and the PTS+ strains. These
results, and those obtained when trying to reduce acetate
overflow, show that modulation of galP and glk expres-
sion level in a PTS- Glc- strain allows the possibility of con-
trolling glycolytic flux so that the rate of production of
acetate and other fermentation products could be lower of
higher than that of a PTS+ strain.Microbial Cell Factories 2005, 4:14 http://www.microbialcellfactories.com/content/4/1/14
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One example of the improvement of a strain for the pro-
duction of a TCA cycle intermediate is the case of succi-
nate. This is a valuable specialty compound that is
employed as a precursor of industrial chemicals [52]. Suc-
cinate is currently produced from petroleum derivates as a
raw material, but recently, considerable effort has been
applied to the development of microbial strains for the
biotechnological production of this metabolite. These E.
coli strains have extensive modifications to central meta-
bolic pathways, resulting in the redirection of carbon flux
from the EMP and TCA pathways to enzymes isocitrate
lyase (aceA) and succinyl-CoA synthetase (sucC,  sucD),
both leading to the production of succinate [53]. An addi-
tional modification to these strains was the inactivation of
ptsG. In this study, it was determined that a strain with an
inactive ptsG displayed a 22.5% increase in final succinate
concentration, 16.4% increase in succinate molar yield
from glucose and 22% higher specific productivity when
compared with an isogenic ptsG+ strain. These results have
been explained considering that inactivation of ptsG
caused a lower rate of glucose consumption and acetate
production, thus resulting in a more balanced and effi-
cient metabolism [53].
Elimination of carbon catabolic repression for 
the simultaneous consumption of sugar 
mixtures
E. coli has the capacity to select, from a mixture of carbon
sources, the one that affords the highest growth rate. This
response is called carbon catabolite repression (CCR) and
Carbon catabolic repression mechanisms in Escherichia coli Figure 3
Carbon catabolic repression mechanisms in Escherichia coli.
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it is the result of inhibition of sugar transport capacity,
enzyme activities and gene expression by the presence of
a rapidly metabolizable carbon source [54]. The IIAGlc
protein has a central role in CCR. When glucose is present
in the medium, this protein is non-phosphorylated and in
this state it binds to various non-PTS permeases,
inhibiting uptake of non-PTS sugars (Fig. 3). This form of
IIAGlc also binds to the enzyme glycerol kinase (GK),
inhibiting its activity [55]. In addition, non-phosphor-
ylated IIBGlc binds the Mlc repressor protein, thus relieving
its repression from genes ptsHI, ptsG, mlc, manXYZ and
malT  [49]. When glucose is absent from the culture
medium, IIAGlc and IIBGlc will be mainly in their phospho-
rylated state. In this condition, IIAGlc~P binds to the
enzyme adenylate cyclase (AC) activating its cAMP bio-
synthetic capacity. Therefore, cAMP concentration
increases in the cell, binding to the cAMP receptor protein
(CRP) and causing the induction of catabolite-repressed
genes [56]. Protein IIBGlc~P looses its capacity to bind
Mlc, so this protein binds to its target operator sequences,
causing repression of genes involved in glucose uptake
[49]. Proteins EI and Hpr also have regulatory functions.
In its non-phosphorylated state, Hpr activates glycogen
phosphorylase (GP), whereas Hpr~P has a similar effect
on BglG, a transcriptional activator of the bgl operon that
encodes proteins involved in β -glucosidic sugars uptake
and utilization [57,58]. Non-phosphorylated EI has been
shown to bind to the chemotaxis protein CheA, inhibiting
its autophosphorylation and thus causing smooth swim-
ming [59].
These data shows that PTS forms part of a regulatory net-
work involved in coordinating cellular processes related
to the cell's capacity to find, select, transport and metabo-
lize a large number of carbon sources [12-60]. In addition,
it has been demonstrated that protein IIAGlc exerts nega-
tive control of expression for the gene encoding the σ S
subunit of RNA polymerase [59]. Therefore, it can be
expected that alterations to PTS components should have
wide-ranging effects on the cell's physiology. Regarding
the regulatory functions of PTS, its modification for strain
improvement purposes has focused on reducing or elimi-
nating CCR.
Lignocellulose derived from agricultural residues is a
potential low-cost feedstock for the production of differ-
ent types of chemicals by fermentation, among them, fuel
ethanol and L-lactic acid [62,63]. Hydrolysis of lignocel-
lulose yields a mixture of sugars containing mainly glu-
cose, arabinose and xylose [64]. Due to CCR, E. coli
displays sequential sugar consumption when it is grown
in media derived from lignocellulose hydrolyzates. Simul-
taneous consumption of sugars in a mixture would be
advantageous in a fermentative production process, as
this would eliminate diauxic growth, therefore, reducing
operating time and increasing productivity.
Different groups have explored strategies to disrupt CCR
by inactivating PTS components. Starting from an E. coli
strain engineered for increased ethanol production by the
introduction of genes pdcZm and adhBZm, mutant deriva-
tives were selected on the basis of resistance to the PEP
analog fosfomycin [65]. Fosfomycin is used to select for
mutants that cannot transport PTS sugars and mutations
usually occur in the ptsI gene [66]. Some of these mutant
strains lost the capacity to ferment PTS sugars, while oth-
ers retained it. The specific genetic lesions in these strains
were not determined. When compared to the parental
wild type strain, a mutant strain from the latter class dis-
played a higher rate of sugars consumption when growing
in a medium supplemented with a mixture containing 30
g/l each of glucose, arabinose and xylose. In addition, this
mutant produced 20% more ethanol than the wild type
when growing in medium containing 120 g/l xylose as
sole carbon source [65].
The effect of ptsG inactivation on the pattern of sugar mix-
ture utilization and its impact on ethanol production has
been determined [67]. In cultures performed with mini-
mal medium containing 2 g/l each of either glucose and
arabinose or glucose and xylose, a wild type strain dis-
played sequential glucose-pentose utilization, whereas
the ptsG mutant consumed these sugars simultaneously.
In both conditions, the ptsG mutant consumed the total
amount of sugars in about half the time, when compared
to the wild type strain. Both strains were transformed with
a plasmid bearing the pdcZm and adhBZm genes and the
transformants were cultured in LB medium supplemented
with 4 g/l each of either glucose and xylose. Under these
conditions, the ethanol yields of the ptsG and wild type
strains were 3.5% and 2.9% (w/v), respectively [67]. A
similar study was performed with a PTS-  Glc+  strain
obtained from a PTS- Glc- mutant by a continuous culture
selection method [68,33]. When grown in a medium con-
taining 1 g/l each of glucose, arabinose and xylose, the
PTS- Glc+ strain consumed the total amount of sugars in
the medium 16% faster than an isogenic PTS+strain. In
addition, acetate produced during growth was completely
consumed by the PTS-  Glc+  strain, whereas 0.4 g/l
remained in the PTS+ strain culture [68].
L-lactic acid is a chemical precursor with many different
applications in industry [69]. E. coli strains engineered for
the production of lactic acid have been developed by
inactivation of the genes encoding pyruvate formate lyase
and lactate dehydrogenase. The double mutant strain was
then transformed with a plasmid carrying a gene encoding
the L-specific lactic acid dehydrogenase from Streptococcus
bovis, thus generating an engineered strain that producesMicrobial Cell Factories 2005, 4:14 http://www.microbialcellfactories.com/content/4/1/14
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only L-lactate. From this strain, a ptsG mutant was gener-
ated and compared with other isogenic strains in cultures
performed with medium containing 50 g/l each of glucose
and xylose. The ptsG mutant fermented 75% of the xylose,
while for ptsG+  strains this value was 18–20%.
Furthermore, lactate yield for the ptsG  and wild type
strains were 0.77 (g lactic acid/ g sugar) and 0.48 (g/g),
respectively [63].
Perspectives
As shown by the examples presented here, inactivation of
specific PTS components or the total functional replace-
ment of PTS-dependent glucose transport capacity in wild
type and engineered strains can result in significant
improvements for the production of different classes of
compounds. Although some of the strain improvements
generated by PTS modification are product-specific, dis-
ruption of CCR to improve utilization of sugar mixtures
from inexpensive lignocellulosic hydrolysates would be
expected to be non product-specific and thus have a posi-
tive impact in several of the current biotechnological pro-
duction processes for bulk and commodity compounds. It
would be expected that some of the gains observed by
modifying or replacing the glucose PTS components,
could also be obtained when the same strategies are
applied to the components for other PTS sugars. This is an
issue that has not been explored yet, however, it is partic-
ularly revelant for production processes based on the use
as raw materials of sugar mixtures containing different
PTS sugars.
The PTS is widely distributed among Bacteria, therefore,
some of the improvements observed in E. coli could be
translated to other species used in industrial processes like
the Gram-positive bacteria Bacillus subtilis and Corynebac-
terium glutamicum. Considering the significant differences
between Gram-negative and Gram-positive bacteria with
regard to central metabolic network architecture, PTS
complex composition and CCR regulation, it remains to
be determined what would be the consequences of PTS
modification in this group of bacteria in an industrial pro-
duction context.
The PTS is a complex system deeply integrated to the cell's
physiology. Much work remains to be done to fully under-
stand the outcome of its modifications. A genomic
approach to the study of PTS- strains, including transcrip-
tome, proteome and metabolome analysis, will be funda-
mental to comprehend the extent of the participation of
this system in several of the cell's processes. This knowl-
edge will be valuable to help in the definition of strain
design and improvement strategies by metabolic
engineering.
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